Rap: A Phase Ii Trial With Ramucirumab, Avelumab, And Paclitaxel As Second Line Treatment In Gastro-Esophageal Adenocarcinoma Of The Arbeitsgemeinschaft Internistische Onkologie (Aio).
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要